ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New to The Street to Broadcast Live on Bloomberg Tonight at 6:30 PM EST as Sponsored Programming, Spotlighting BioVie (BIVI), RoadZen (RDZN), HPB, and Sustainable Innovation With Shark Tank’s Kevin Harrington and Sustainable Green Team (SGTM)

NEW YORK, NY / ACCESS Newswire / February 22, 2025 / New to The Street is set to deliver an engaging broadcast on Bloomberg Television this evening at 6:30 PM EST as sponsored programming. The show will spotlight breakthrough companies and innovative market strategies that are shaping the future of healthcare, technology, and sustainable development.

A key highlight of the broadcast will be an exclusive segment with BioVie Inc. (NASDAQ: BIVI) CEO Cuong Do speaking with Jane King about the company's investigational drug bezisterim, Do revealed that the drug has shown promising clinical benefits: Parkinson's patients are experiencing improved muscle control, and Alzheimer's patients have demonstrated a 68% slowing of cognitive decline compared to placebo after just six months of treatment. Potentially the first new therapy for Parkinsons in over 50 years. The new clinical study is enrolling now go to Sunrisepd.com for more info.

In addition, the program will feature:

  • Roadzen Inc. (Nasdaq:RDZN): A global technology company transforming auto insurance with advanced artificial intelligence (AI), driving innovation in telematics, generative AI, and computer vision. Rohan Malhotra , the CEO of RoadZen, explained that as cars evolve into highly connected devices-essentially "iPhones on wheels"-there's going to be a wave of innovation not just in the vehicles themselves but in all the related services. Here's what he outlined:

  • Expanding Ecosystem: As vehicles become more digitally advanced, areas such as identity verification, cybersecurity, in-car entertainment, and insurance will see rapid innovation.

  • Insurance Challenges: For auto insurance, the key decisions involve:

    • Pricing: Determining the right premium.

    • Selling: Effectively marketing and distributing policies.

    • Claims Processing: Handling claims quickly and fairly.

    • Safety: Enhancing vehicle safety, which in turn can lower risk and improve profitability.

  • RoadZen's AI Advantage:
    RoadZen uses proprietary AI algorithms to simplify these four critical areas. By doing so, they aim to:

    • Lower underwriting costs.

    • Reduce premiums.

    • Increase transparency in the insurance process.

In essence, RoadZen's mission is to harness AI to transform auto insurance into a more efficient, customer-friendly, and cost-effective service as our cars become smarter and more connected.

  • HPB: A pioneering company specializing in next-generation, solid-state batteries that are non-flammable, extremely durable, and environmentally friendly.

  • Sustainable Innovation Segment: Featuring Shark Tank's Kevin Harrington alongside the Sustainable Green Team (SGTM), leaders in providing sustainable, eco-friendly solutions focused on improving soil health and ecological stability.

Tune in tonight on Bloomberg Television for in-depth interviews, exclusive insights, and a look at the innovations driving advancements across multiple industries.

About BioVie Inc.
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (long COVID, AD and PD) and advanced liver disease. In neurodegenerative disease, the Company's drug candidate bezisterim inhibits inflammatory activation of extracellular signal-regulated kinase and the transcription factor nuclear factor-κB, and the associated neuroinflammation and insulin resistance but not ERK and NFκB homeostatic functions (e.g., insulin signaling and neuron growth and survival). Both neuroinflammation and insulin resistance are drivers of AD and PD. Persistent systematic inflammation and neuroinflammation are key features in patients with neurological symptoms of long COVID. In liver disease, the Company's Orphan drug candidate BIV201 (continuous infusion terlipressin), with FDA Fast Track status, is being evaluated and discussed with guidance received from the FDA regarding the design of Phase 3 clinical testing of BIV201 for the reduction of further decompensation in participants with liver cirrhosis and ascites. The active agent is approved in the U.S. and in about 40 countries for related complications of advanced liver cirrhosis. For more information, visit www.bioviepharma.com.

About Roadzen Inc.
Roadzen Inc. (Nasdaq:RDZN) is a global technology company transforming auto insurance using advanced artificial intelligence (AI). Thousands of clients-from the world's leading insurers and carmakers to fleets and dealerships-utilize Roadzen's technology to build new products, process claims, and enhance road safety. To learn more, visit www.roadzen.ai.

About Sustainable Green Team (SGTM)
Sustainable Green Team ($SGTM) is a leading provider of environmentally sustainable solutions focused on improving soil health and ecological stability. By addressing critical environmental challenges through innovative products and services, SGTM supports sustainable agricultural and industrial practices worldwide. For more information, visit www.sustainablegreenteam.com.

About HPB
High Performance Battery Technology GmbH is a young company specializing in the research and development of next-generation batteries with outstanding properties. The HPB Solid-State Battery is characterized by its non-flammability, extreme durability, and significantly improved environmental profile - and is already ready for series production due to an innovative manufacturing process. Based in Bonn, Germany, HPB is a wholly owned subsidiary of High Performance Battery Holding AG, based in Teufen, Switzerland, which finances its research. For additional details, visit highperformancebattery.ch.

About New to The Street
New to The Street is a premier broadcast program with over 16 years in business, dedicated to delivering insightful commentary and in-depth analysis on emerging trends in healthcare, technology, and sustainability. Now on show number 630, the program boasts over 2.2 million YouTube subscribers and more than 600,000 followers and subscribers across X, LinkedIn (company-wide), Instagram, and Facebook, reaching over 800 million homes nationwide through real TV broadcasting every month. With exclusive interviews and breakthrough stories, New to The Street is your go-to source for market insights and innovative developments. (51) New to The Street TV - YouTube

The show is sponsored by ACURX Pharmaceuticals $ACXP https://youtu.be/3U--JarssP0?si=EEnlcPTKG2YbjbmO

Contact Information

Monica Brennan
Head of Operations
monica@newtothestreet.com

SOURCE: New to The Street

Related Images



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.